Real-World Efficacy of Neoadjuvant Nivolumab versus Pembrolizumab in Resectable NSCLC: A Propensity Score-Matched Comparative Analysis
Junghee Lee, JeongA Son, Yeong Jeong Jeon, Seong Yong Park, Hong Kwan Kim, Yong Soo Choi, Jong Ho Cho
책임저자: Jong Ho Cho
성균관대학교 삼성서울병원
발표자: Junghee Lee, E-mail : ts.junghee@gmail.com